Evidence map›Paper›PMID 40380093›Full record

Observational studyBMC nephrology2025

Risk factors associated with Indian type 2 diabetes patients with chronic kidney disease: CITE study, a cross-sectional, real-world, observational study.

Ajay Kumar, Anirban Mazumdar, A K Bhattacharjee, Arvind Gupta, Arundhati Dasgupta, Binayak Sinha, Banshi Saboo, Chitra Selvan, Ghanshyam Goyal, Jaganmohan Balaji and 19 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ajay KumarPrivate Clinic, Patna, India.
Anirban MazumdarKPC Medical College, Kolkata, India.
A K BhattacharjeeILS Hospital, Agartala, India.
Arvind GuptaRHL-Rajasthan Hospital, Jaipur, India.
Arundhati DasguptaRudraksh Superspecialist Care, Siliguri, India.
Binayak SinhaManipal Hospitals, Kolkata, India.
Banshi SabooDiabetes Care & Hormone Clinic, Ahmedabad, India.
Chitra SelvanM.S. Ramaiah Medical College, Bengaluru, India.
Ghanshyam GoyalILS Hospital, Kolkata, India.
Jaganmohan BalajiApollo Sugar Clinic, Bengaluru, India.
Krishna G SeshadriApollo Hospital, Chennai, India.
Kalyan K GangopadhyayPeerless Hospital & B.K. Roy Research Centre, Kolkata, India.
G Vijay KumarApollo Hospital, Chennai, India.
Manoj ChawlaLina Diabetes Care Centre, Mumbai, India.
Mohua SikdarApollo Clinic, Burdwan, India.
Nilakshi DekaApollo Hospital, Guwahati, India.
N K SinghDiabetes and Heart Research Center, Dhanbad, India.
Purvi ChawlaLina Diabetes Care Centre, Mumbai, India.
Pratap JetwaniJethwani Diabetes Care Center, Rajkot, India.
Rajiv KovilDr Kovil's Diabetes Care Centre, Mumbai, India.
Samit GhosalNightingale Hospital, Kolkata, India. ramdasghosal@gmail.com.
Subir RayApollo Hospital, Kolkata, India.
Sudip ChatterjeePark Clinic, Kolkata, India.
Sruti ChandrasekharanRela Hospital, Chennai, India.
Sambit DasApollo Hospital, Bhubaneshwar, India.
Subhajyoti GhoshApollo Hospital, Dibrugarh, India.
Sonali PatangeDr. Sonali Patanges Speciality Diabetes Centre (A CGMS Speciality), Mumbai, India.
Sanjay ReddyCentre for Diabetes & Endocrine Care, Bengaluru, India.
T SurekhaMedswan, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 diabetes (T2DM) is the leading cause of chronic kidney disease (CKD) worldwide. Identifying clinical and laboratory associations with chronic kidney disease (CKD) in type 2 diabetes (T2DM) can help physicians target modifiable risk factors. In light of limited data from India, the CITE (CKD in Indian T2DM Evaluation) study was conducted.

methodsThe multicenter, cross-sectional CITE study included 3,325 patients from 28 centres across India over a three-month period. CKD was defined as a persistent decline in kidney function (eGFR < 60 ml/min/1.73 m² for ≥ 3 months) or an elevated urine albumin-to-creatinine ratio (UACR) in at least two samples. Descriptive statistics summarised patient characteristics, while logistic regression analyses identified significant risk factors for CKD.

resultsThe prevalence of CKD in T2DM was 32%, with a median patient age of 59.9 years and 60.72% having a T2DM duration > 10 years. Reduced eGFR (< 60 ml/min/1.73 m²) was associated with older age (OR: 2.47, 95% CI 2.11-2.88, P < 0.001), longer T2DM duration (OR: 2.28, 95% CI 1.77-2.93, P < 0.001), higher HbA1c (OR: 1.039, 95% CI 1.001-1.079, P = 0.046), and elevated SBP (OR: 1.005, 95% CI 1.002-1.009, P = 0.003). Macroalbuminuria (UACR > 300 mg/g) was linked to non-vegetarian diet (OR: 1.95, 95% CI: 1.59-2.40, P < 0.001) and tobacco use (OR: 1.42, 95% CI: 1.17-1.73, P < 0.001). CKD increased comorbidity odds.

conclusionThe CITE study highlights the prevalence of CKD (32%) in Indian patients with T2DM and identifies clinical and laboratory factors associated with CKD, including age ≥ 60 years, T2DM duration, SBP, HbA1c, tobacco use, non-vegetarian diet, and comorbidities. Longitudinal studies are needed to confirm these associations and evaluate causality.

Indexed as

Diabetes Mellitus, Type 2Diabetic NephropathiesRenal Insufficiency, ChronicAdultAgedAlbuminuriaCross-Sectional StudiesFemaleHumansIndiaMaleMiddle AgedPrevalenceRisk FactorsCKDCross-sectional studyLogistic regression analysisT2DM

Identifiers

PMID40380093
PMCPMC12083097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.